NASA Goddard Space Flight Center Internal Memo Regarding Employee Use of Cannabidiol (CBD) Oil
This HR Message is being delivered to you via HRMES On Behalf Of: Agency Drug Testing Program Manager
Cannabidiol (CBD) oil, which is a chemical compound extracted from the flowers and buds of the hemp (cannabis sativa) plant, has increased in popularity as a result of the claims that it is a natural remedy for common ailments such as chronic pain and anxiety. There are no standards governing the manufacturing of products containing CBDs; however, products that contain pure CBDs typically has less than 0.3% of the Tetrahydrocannabinol (THC), the psychoactive compound of the cannabis plant associated with the sensation of feeling “high.” The lack of standards means there are CBD products being marketed that contains a sufficient level of THC to cause a positive drug test result. Please be aware that, the use of any compounds or substances not approved by the FDA cannot be used as a legitimate medical explanation for a positive drug test result.
As a reminder, the use of illegal drugs by federal employees is not permissible under any circumstances, regardless of state and/or local laws; this includes the use of Marijuana or products that contains THC for recreational and/or medical purposes.
NASA is authorized to conduct pre-employment testing of any individual who will occupy a testing designated position (TDP) and Random testing of employees who occupy a TDP. All employees are subject to testing under provisions for reasonable suspicion and post-accident and/or unsafe practice testing regardless of the TDP designation of their position.
For more information about NASA’s Drug-Free Workplace Program, please see the NSSC Drug Testing page at https://www.nssc.nasa.gov/drugtesting.
